% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • alvin_s60 alvin_s60 Jun 21, 2009 11:17 AM Flag

    The investor who bought the 12 million shares in Epicept

    LIPPERT/HEILSHORN & ASSOCIATES is a leading independent investor relations firm. As IR specialists with over 25 years of experience, we partner with public and soon-to-be public companies to create and support best practices investor and media relations programs. By focusing on the development of public company identity and the communication of strategic vision, we build awareness, enthusiasm, and sponsorship among target audiences in the investment community to maximize valuation. Our programs deliver measurable results so clients can assess the impact of their investor relations initiatives

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.42-0.01(-2.33%)Feb 5 3:59 PMEST